Physician profile
Stephen Griffin
NPI 1508028283
$4,729.43
in general payments reported to CMS, 2019-2025
12 companies · $96.30 in 2025
The $96.30 reported for 2025 was less than what a typical Obstetrics & Gynecology provider received nationally (typical 2025 total: $158).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $3,017 · 2020: $103 · 2021: $229 · 2023: $82.08 · 2024: $1,203 · 2025: $96.30.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Travel and Lodging: $893 · Food and Beverage: $488.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Travel and Lodging | $892.61 |
| Food and Beverage | $488.35 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Intuitive Surgical, INC. | $3,000.00 | 2019 | |
| Medical Device Business Services, INC. | $1,084.92 | 2024 | Harmonic |
| Abbvie INC. | $319.71 | 2020-2021 | |
| Ethicon US, LLC | $111.50 | 2024-2025 | Enseal X1, Enseal, Stratafix |
| Hologic Sales and Service, LLC | $50.97 | 2025 | Myosure Tissue Removal Device, Fluent Fluid Management System, Novasure |
| Coopersurgical, INC. | $31.36 | 2023 | Summit Doppler |
| Innovation Technologies INC | $31.01 | 2023 | Irrisept |
| Bayer Healthcare Pharmaceuticals INC. | $28.76 | 2019-2020 | |
| Astellas Pharma US INC | $22.27 | 2024 | Veozah |
| Baxter Healthcare | $19.71 | 2023 | Tisseel |
| Medtronic, INC. | $14.64 | 2025 | Ligasure |
| Sanofi Pasteur INC. | $14.58 | 2025 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Stephen Griffin listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.